Specialized testing
Delivering value beyond the test result
Our commitment to improving patient outcomes propels the development of clinically impactful, patient-focused testing. Supported by clinical physicians and laboratory scientists with unmatched experience and expertise, our assays — several of which are unavailable elsewhere — deliver actionable answers that improve patient lives.
Our data-driven, evidence-based tests provide actionable answers for patients that clarify each patient’s unique healthcare journey.
Specialty testing menu
Collaborations that power innovation
We relentlessly innovate on behalf of patients to build tests of the future to help physicians impact more lives. Mayo Clinic Laboratories scientists and physicians are leaders in their fields and at the forefront of translating new ideas into meaningful solutions. Through groundbreaking collaborations with healthcare companies and diagnostics leaders, we simplify access to new and advanced laboratory tests.
Commitment to education
The exchange of knowledge is a founding principle at Mayo Clinic. In this tradition, we provide a wide range of education offerings and outreach consultation to help you drive continual improvement.
- Regionally based clinical specialists help guide best practices through physician education.
- Access to Mayo Clinic Laboratories' education offerings and Insight articles.
- Many courses offer CME credits.
- Online trainings are available, such as “Dangerous Goods Shipping,” and include printable certificates.
News and updates
The latest
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss a new collaboration and a Mayo Clinic-led study focused on detecting DNA mutations. Later, Dr. Pritt welcomes Andrew McKeon, M.B., B.Ch., M.D., and Anastasia Zekeridou, M.D., Ph.D., co-directors of Mayo Clinic’s Neuroimmunology Laboratory, to discuss how they are advancing patient care.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss a new collaboration and a Mayo Clinic-led study focused on detecting DNA mutations. Later, Dr. Pritt welcomes Andrew McKeon, M.B., B.Ch., M.D., and Anastasia Zekeridou, M.D., Ph.D., co-directors of Mayo Clinic’s Neuroimmunology Laboratory, to discuss how they are advancing patient care.
Register now – Jan. 13, 2027 | Review key 2027 pathology and laboratory CPT code updates, Medicare reimbursement changes, coding resources, and the process for proposing and pricing new codes.
Strategic Lab Collaborations help Mayo Clinic Laboratories accelerate innovation and expand access to advanced diagnostics.
Dr. Chris Garcia discusses how diagnostics, data integration, and early laboratory engagement can improve clinical trial participation.
Explore how different types of psychological safety help people move from feeling included to confidently contributing to respectfully challenging ideas.
Mary Jo Williamson shares how trust, curiosity, transparency, and a strong mission help organizations build change-ready, future-focused cultures.
Due to the Thanksgiving holiday (recognized on Thursday, November 26), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered.
This program reviews urine drug testing for stimulants and phencyclidine (PCP), with an emphasis on the advantages and limitations of traditional immunoassays and targeted mass spectrometry-based screening.
Register now – Dec. 9, 2025 | This webinar will highlight federal and state regulatory updates affecting hospital laboratory outreach programs, including billing, reimbursement, and government enforcement.
In the third quarter of 2026, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.
In this episode of the “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, is joined by Rachael Hulshizer, director of Market Access Payer Innovation at Mayo Clinic Laboratories, to discuss payer policy and strategies for helping patients avoid unnecessary out-of-pocket costs for medically necessary testing.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss the future of diagnostics. Later, Eric Hsi, M.D., chair of Mayo Clinic’s Department of Laboratory Medicine and Pathology in Rochester, shares how the department is advancing innovation and helping transform healthcare through laboratory medicine.